Open AccessIncreased Risk of Severe Infant Anemia After Exposure to Maternal HAART, Botswana
Author(s) -
Scott DrydenPeterson,
Roger Shapiro,
Michael D. Hughes,
Kathleen M. Powis,
Anthony Ogwu,
Claire Moffat,
Sikhulile Moyo,
Joseph Makhema,
Max Essex,
Shahin Lockman
Publication year - 2011
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e31820bd2b6
Subject(s) - zidovudine , medicine , anemia , in utero , pediatrics , pregnancy , obstetrics , immunology , fetus , viral disease , human immunodeficiency virus (hiv) , biology , genetics
Maternal highly-active antiretroviral therapy (HAART) reduces mother-to-child HIV transmission but may increase the risk for infant anemia.